Company / EPS (Diluted)
Indivior EPS (Diluted) History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.92
FY2025
5-year range
-$0.92 / -$0.32
FY2022-FY2025
Trend
-187.5%
vs FY2024
Sector context
#85 of 204
Health Care
What the data says
At $-0.92, Indivior's eps (diluted) ranks #85 of 204 in the Health Care sector.
Based on SEC 10-K filings.
-0.92 in FY2025.
Remained stable around $-0.92 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#85 of 204 in Health CareTop 42% of 204This company -$0.92 Sector average -$0.89
▼
-3.8% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 187.5% year-over-year.
- Ranks #85 out of 204 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.92 | -187.5% |
| FY2024 | -$0.32 | +65.2% |
| FY2023 | -$0.92 | -187.5% |
| FY2022 | -$0.32 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026